Featured Chrome Extensions:

Casey IRACs are produced by an AI that analyzes the opinion’s content to construct its analysis. While we strive for accuracy, the output may not be flawless. For a complete and precise understanding, please refer to the linked opinions above.

Keywords

appealpatent
patentrespondent

Related Cases

Apotex Inc. v. UCB, Inc., 763 F.3d 1354, 112 U.S.P.Q.2d 1081
View Case »
Maxwell v. J. Baker, Inc., 86 F.3d 1098, 64 USLW 2816, 39 U.S.P.Q.2d 1001
View Case »
Burlington Industries, Inc. v. Dayco Corp., 849 F.2d 1418, 7 U.S.P.Q.2d 1158
View Case »
Medicines Co. v. Hospira, Inc., 791 F.3d 1368, 115 U.S.P.Q.2d 1587
View Case »
Newman v. Quigg, 877 F.2d 1575, 11 U.S.P.Q.2d 1340
View Case »
Justia Law Link
LexisNexis Link
Westlaw Link
CourtListener Link
Oyez Link

Dawson Chemical Co. v. Rohm and Haas Co., 448 U.S. 176, 100 S.Ct. 2601, 65 L.Ed.2d 696, 206 U.S.P.Q. 385, 1980-2 Trade Cases P 63,494

Facts

The case involves a patent holder, Rohm & Haas, who owned a patent for a method of applying the herbicide propanil. The company sued Dawson Chemical Co. for contributory infringement, alleging that Dawson sold propanil with instructions that facilitated infringement of Rohm & Haas's patent. Dawson argued that Rohm & Haas had engaged in patent misuse by refusing to license competitors and tying the sale of propanil to the patented method. The District Court initially ruled in favor of Dawson, but the Court of Appeals reversed this decision, stating that Rohm & Haas's actions did not constitute patent misuse.

Respondent filed suit in Federal District Court, seeking injunctive relief and alleging that petitioners contributed to infringement of its patent rights by farmers who purchased and used petitioners' propanil and that petitioners induced such infringement by instructing the farmers how to apply the herbicide.

Issue

Whether the patent holder's actions in selling propanil and refusing to license competitors constituted patent misuse, thereby barring it from seeking relief against contributory infringement.

Whether the owner of a patent on a chemical process is guilty of patent misuse, and therefore is barred from seeking relief against contributory infringement of its patent rights, if it exploits the patent only in conjunction with the sale of an unpatented article that constitutes a material part of the invention and is not suited for commercial use outside the scope of the patent claims.

Rule

Section 271(d) provides that '[n]o patent owner otherwise entitled to relief for infringement or contributory infringement of a patent shall be denied relief or deemed guilty of misuse or illegal extension of the patent right by reason of his having done one or more of the following: (1) derived revenue from acts which if performed by another without his consent would constitute contributory infringement of the patent; (2) licensed or authorized another to perform acts which if performed without his consent would constitute contributory infringement of the patent; (3) sought to enforce his patent rights against infringement or contributory infringement.'

Analysis

Conclusion

The court held that Rohm & Haas did not engage in patent misuse and was entitled to seek relief against contributory infringement.

Held: Respondent has not engaged in patent misuse, either by its method of selling propanil, or by its refusal to license others to sell that commodity.

Who won?

Rohm & Haas prevailed in this case as the court found that their actions in selling propanil and enforcing their patent rights were within the bounds of the law. The court emphasized that the statutory framework established by Congress in 1952 allowed patent holders to control nonstaple goods essential to their inventions without being accused of patent misuse. This ruling reinforced the patent holder's rights and clarified the limitations of the patent misuse doctrine.

You must be